研究单位：[1]Sunshine Lake Pharma Co., Ltd.[2]Peking University People's Hospital[3]Beijing Ditan Hospital Affiliated to Capital Medical University[4]Tongji Hospital Affiliated to Tongji Medical College of Huazhong University Science & Technology
The safety, tolerability and antiviral activity of DAG181/SOF in treatment-naive and treatment-experienced patients with chronic hepatitis C virus (HCV) genotype 1 infection.
